Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7150/ijms.24755 http://scihub22266oqcxt.onion/10.7150/ijms.24755 C6036079!6036079!30008587     free     free     free       Int+J+Med+Sci 2018 ; 15 (8): 782-7 Nephropedia Template TP {{tp|p=30008587|t=2018. Hyperbaric Oxygen Therapy in Liver Diseases |pdf=|usr=}}{{30008587}} gab.com Text Hyperbaric Oxygen Therapy in Liver Diseases JO: Int J Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=30008587 #FOAvip Hyperbaric oxygen therapy (HBOT) is an efficient therapeutic option to improve progress of lots of diseases especially hypoxia-related injuries, and has been clinically established as a wide-used therapy for patients with carbon monoxide poisoning, decompression sickness, arterial gas embolism, problematic wound, and so on. In the liver, most studies positively evaluated HBOT as a potential therapeutic option for liver transplantation, acute liver injury, nonalcoholic steatohepatitis, fibrosis and cancer, especially for hepatic artery thrombosis. This might mainly attribute to the anti-oxidation and anti-inflammation of HBOT. However, some controversies are existed, possibly due to hyperbaric oxygen toxicity. This review summarizes the current understandings of the role of HBOT in liver diseases and hepatic regeneration. Future understanding of HBOT in clinical trials and its in-depth mechanisms may contribute to the development of this novel adjuvant strategy for clinical therapy of liver diseases. Twit Text FOAVip Hyperbaric Oxygen Therapy in Liver Diseases ????Int J Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=30008587 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=30008587 #FOAvip English Wikipedia <ref>{{Cite pmid|30008587}}</ref> Hyperbaric Oxygen Therapy in Liver Diseases #MMPMID30008587 Sun Y; Wen Y; Shen C; Zhu Y; You W; Meng Y; Chen L; Feng Y; Yang X; Chen ZB Int J Med Sci 2018[]; 15 (8): 782-7 PMID30008587show ga Hyperbaric oxygen therapy (HBOT) is an efficient therapeutic option to improve progress of lots of diseases especially hypoxia-related injuries, and has been clinically established as a wide-used therapy for patients with carbon monoxide poisoning, decompression sickness, arterial gas embolism, problematic wound, and so on. In the liver, most studies positively evaluated HBOT as a potential therapeutic option for liver transplantation, acute liver injury, nonalcoholic steatohepatitis, fibrosis and cancer, especially for hepatic artery thrombosis. This might mainly attribute to the anti-oxidation and anti-inflammation of HBOT. However, some controversies are existed, possibly due to hyperbaric oxygen toxicity. This review summarizes the current understandings of the role of HBOT in liver diseases and hepatic regeneration. Future understanding of HBOT in clinical trials and its in-depth mechanisms may contribute to the development of this novel adjuvant strategy for clinical therapy of liver diseases. äHyperbaric Oxygen Therapy in Liver Diseases (epmc).pdf DeepDyve Pubget Overpricing